Related Experiment Video
Updated: Aug 28, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Epigenomics and Ayurgenomics: Molecular Analysis of Ayurvedic Prakriti in Personalized Healthcare
Amit R Nampalliwar1, Swati N Khandale2, Pooja Singh3
1Department of Roga Nidan and Vikriti Vigyan (Diagnostic Procedures and Pathology), Government Ayurved College and Hospital, Bilaspur, IND.
Abstract:
Personalized healthcare increasingly requires models that explain individual variation in disease risk, prevention, and treatment response. Ayurvedic Prakriti offers a constitution-based framework for classifying human variability through Vata, Pitta, and Kapha phenotypes, while Ayurgenomics attempts to connect these traditional classifications with molecular biology. Despite growing interest, the biological relationship between Prakriti, epigenomic regulation, and precision healthcare remains insufficiently established, particularly because available evidence is limited by small cohorts, heterogeneous assessment tools, and incomplete biomarker validation. This review examines the molecular relevance of Prakriti by analyzing evidence from genomics, epigenomics, transcriptomics, proteomics, metabolomics, pharmacogenomics, and systems biology. Literature was evaluated thematically to identify constitution-specific molecular signatures, disease susceptibility patterns, lifestyle-related epigenetic influences, and translational applications in individualized healthcare. Current findings suggest that Prakriti types may be associated with distinct biological profiles involving metabolism, inflammation, immune regulation, oxidative stress, stress adaptation, and drug response. Epigenomic mechanisms may further explain how diet, lifestyle, environment, aging, and stress modify gene expression within constitution-specific contexts. Integrating Ayurgenomics with multi-omics platforms may support preventive screening, personalized nutrition, lifestyle planning, and precision therapeutics. Stronger validation through standardized tools, longitudinal studies, and clinical trials remains essential.
Related Concept Videos
Pharmacogenetics and Pharmacogenomics: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genomics
